Cambridge-based company Phico Therapeutics has entered liquidation. Founded in 2000 by Dr Heather Fairhead, Phico was developing a platform for a new generation of antibiotics to overcome antibacterial resistance, recognised internationally as one of the biggest threats facing global health and the effective treatment of certain diseases. The technology represented the efforts of more than … Continue reading BGF-backed Phico enters liquidation